• English
  • Français
  • Русский

R&D

MUP has one of the largest generic R&D team in the MENA region, committed to bring science and innovation to provide high quality generic drugs that improve people’s lives. MUP pursuing technological supremacy in a wide range of dosage forms, (Oral liquid and solid dosage, injectable solutions and suspensions, nasal drops, ophthalmic preparations, creams, gels and ointments), drug delivery technologies (Mixed micelles, inclusion complexes, nanosuspensions, liposomes, solid lipid nanoparticles, lyophilization) and therapeutic areas. R&D team has a good understanding of intellectual property landscape that enabled MUP shifted from localizing products to product development- a step up in sophistication.

  • Methodology and Stability Studies Group (MSSG)
  • Research and Development Group (RDG)
  • Research Projects Group (RPG)
  • This group focusing in establishing innovative platform(s) technologies to develop unique, differentiated products based on currently available drugs or combinations to augment therapeutics of problematic drugs and to improve patient compliance through enhance absorption thus reduced dose or dosing frequency, or reduction of certain side effects associated with existing commercialized drug formulations.
  • This group efforts in development of differentiated formulations, where they launched several effective and innovative products as Rapifen™ and Phytovit MM™.
A Retrospective Publications and Scientific Activities by MUP Scientists and Research Teams
MUP has formulated their pharmaceuticals to contain the exact same chemical and to produce the same beneficial effects as the original brand name products they replace. To ensure therapeutic equivalence (strength, quality, purity and identity), bioequivalence studies in humans are conducted. The bioequivalence study compares the bioavailability of the generic drug to the bioavailability of the reference innovative drug, in terms of rate and extent of absorption throughout the gastrointestinal (GI) tract. A similar rate and extent of absorption indicate that both medicines have a matching therapeutic effect and equal safety and efficacy profiles.
 

Patency

MUP is  a pioneer pharmaceutical corporate in MENA region as it gained several patents in the area of pharmaceutical drug formulation for several products as NSAIs and vitamins .

More
 
 

Patency

MUP is  a pioneer pharmaceutical corporate in MENA region as it gained several patents in the area of pharmaceutical drug formulation for several products as NSAIs and vitamins .

More

Pipeline

 

MUP currently has a considerable pipeline; representing a wide variety of therapeutic areas. Meanwhile MUP carries out its researches and development activities that covers the areas of designing new products, developing the already existing products and innovating  new methods of manufacturing, focusing on developing a complementary mix of small and large molecules across its pipeline in order to address the diverse needs of the patients it serves.

More

 

Medical Union Pharmaceuticals newsletter

Subscribe with your e-mail address to stay up-to-date. We will send you all new MUP news, product launches, Pharmacovigilance cases and our activity to be up-to-date

Go to top